Merck, Eisai’s 007 goes down as Keytruda-Lenvima combo fails in newly diagnosed lung cancer
Merck, Eisai’s 007 goes down as Keytruda-Lenvima combo fails in [...]
Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A
Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M [...]
Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses: report
Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses: report [...]
Amid Aduhelm’s rocky launch, Biogen eyes large-scale layoffs: report
Amid Aduhelm’s rocky launch, Biogen eyes large-scale layoffs: report fkansteiner [...]
BioPure set to add 120 jobs at newly completed UK manufacturing site
BioPure set to add 120 jobs at newly completed UK [...]
Amid consumer spinoff and CEO transition, Johnson & Johnson names new leadership team
Amid consumer spinoff and CEO transition, Johnson & Johnson names [...]
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people preexposure
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people [...]
As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the case
As end of New York opioid trial nears, AbbVie’s Allergan [...]
Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trial
Shkreli’s former company Vyera settles for $40M in antitrust case, [...]
Former pharma CEO plundered millions from his own company, DOJ says
Former pharma CEO plundered millions from his own company, DOJ [...]